@article {2005, title = {The Effect of Cardiac Catheterization Intervention on The Nutritional Status of Children with Acyanotic Congenital Heart Disease}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {April 2023}, pages = {338-342}, type = {Research Article}, chapter = {338}, abstract = {

Background: Intervention is required since malnutrition in children with acyanotic congenital heart disease (CHD) will affect growth, development, and quality of life. Research on the impact of cardiac catheterization on the nutritional health of children with acyanotic CHD is limited, particularly in Indonesia. This study aims to analyze the effect of cardiac catheterization on the nutritional status of children with acyanotic CHD. Methods: A cross-sectional study was conducted between January 2019 and December 2021. The participants of this study were children aged 1-60 months with acyanotic CHD who had undergone cardiac catheterization. We compare the nutritional status of participants in three observation stages, including pre-intervention of catheterization and the 3rd and 6th months post-cardiac catheterization. The parameters of nutritional status are determined according to the mean of Z-scores of weight-for-age (WAZ), length-for-age (LAZ), and weight-for-length (WLZ) of participants. Results: A total of children with acyanotic CHD who underwent catheterization and 49 children were eligible participants. The mean age of children with acyanotic CHD patients who underwent catheterization was 31.51 months, and 89\% of them were 1-5 years. Fifty-three percent of participants who underwent cardiac catheterization were male. The most common acyanotic CHD defects were the Patent Ductus Arteriosus (PDA) among 55.1\% of participants. Significant differences were found in WAZ, LAZ, and WLZ in the measurement of three observation stages (p\<0.05). Conclusion: Interventional cardiac catheterization affects and enhances the nutritional status of children with acyanotic CHD and may be suggested as an initial therapy to further evaluate the disease.

}, keywords = {Acyanotic CHD, Children, Congenital heart disease, Interventional cardiac catheterization., Nutritional status}, doi = {10.5530/pj.2023.15.51}, author = {Muqiemuddin Salim and I Ketut Alit Utamayasa and Roedi Irawan and Irwanto and Azwin Mengindra Putera and Meity Ardiana} } @article {2027, title = {Effects of Magnesium Supplementation on Kidney Function and Phosphate Levels in Children with Chronic Kidney Disease and Hyperphosphatemia: A Double-blind Randomized Clinical Trial}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {June 2023}, pages = {253-257}, type = {Original Article }, chapter = {253}, abstract = {

Background: Pediatric patients with chronic kidney disease (CKD) who have hyperphosphatemia may experience further deterioration in kidney function. This study aims to investigate the effect of magnesium supplementation on the reduction of phosphate levels and improvement of kidney function in children with CKD and hyperphosphatemia, compared to a placebo. Methods: A randomized, double-blind, placebocontrolled trial was conducted at Pediatric Ward in our setting during March-July 2022. We compared oral magnesium supplementation (6 mg/kg body weight/day for two months) with a placebo in children with CKD and hyperphosphatemia (ages 1-18 years old). Patients who were on dialysis and had serum magnesium levels of \<1.6 mg/dL and \>2.4 mg/dL, and were allergic to magnesium supplementation were excluded. A paired T-test and the Wilcoxon signed-rank test were used for statistical analysis. Results: We collected 31 children in the experimental group and 29 children in the placebo group. Phosphate levels were decreased in both the magnesium supplementation and placebo groups (5.4 {\textpm} 0.9 to 4.8 {\textpm} 1.1 mg/dL; p-value = 0.001 and 5.1 {\textpm} 0.6 to 4.3 {\textpm} 1.2 mg/dL; p-value=0.003). However, when compared between groups, the reductions were not significantly different (0.7 vs 0.8; p-value=0.935). A significant improvement was found in kidney function in both groups using estimated Glomerular Filtration Rate (eGFR) (83.4{\textpm}25.3 to 118.8{\textpm}52; p-value=\<0.001 and 86.3{\textpm}28.1 to 96.9 {\textpm} 35.8; p-value=0.004), and the reductions were significantly different (35.4 vs 10.7; p-value=0.045). Conclusion: Magnesium supplements have considerably lower phosphate levels and markedly improved kidney function in children with CKD and hyperphosphatemia.

}, keywords = {Children, Chronic Kidney Disease, Hyperphosphatemia, Kidney Function., Magnesium}, doi = {10.5530/pj.2023.15.71}, author = {Glabela Christiana Pandango and Bambang Purwanto and Risky Vitria Prasetyo} } @article {2047, title = {Model Prediction of Potential Disease Effects from PM2.5 Emission Among School Children in Coming 30 years in South Tangerang}, journal = {Pharmacognosy Journal}, volume = {15}, year = {2023}, month = {June 2023}, pages = {400-404}, type = {Research Article}, chapter = {400}, abstract = {

Background: The largest global environmental health risk factor is the ambient of air pollution, that largely attributed to transportation emissions. One of the main causes of PM2.5 emissions is thought to be onroad transportation. PM2.5 has an impact on health, especially on children that relate to the respiratory system such as asthma, lung cancer, and decreased intelligence. Objective: The research objective was to predict the risk potential disease due to PM2.5 in children from vehicle emissions in South Tangerang City. Method: This research is an observational analytic study with a cross-sectional study design using a dynamic model approach using STELLA software. The environmental and human samples aare used to calculate the exposure level to PM2.5 taken from 32 points in 7 sub-districts of South Tangerang City (North Serpong, Serpong, Pondok Aren, Ciputat, East Ciputat, Pamulang, and Setu). then, meteorological data was also collected. Results: The number of vehicles in the city of South Tangerang is quite high, especially between 11:00 and 15:00 with the majority of vehicles passing by are cars and motorbikes. PM2.5 pollution levels will fluctuate until 2053. The effects of temperature, weather, and humidity might cause an increase in PM2.5 pollutants at specific times. According to the modeling calculation results, even though there are occasions when PM2.5 pollution levels fall, acute respiratory infection (ARI) incidence in children will continue to rise over time. Although PM2.5 emissions fluctuate, exposure to PM2.5 in low concentrations poses a risk to human health.

}, keywords = {Acute respiratory infection., Children, Particulate matter, Transportation}, doi = {10.5530/pj.2023.15.91}, author = {Ernyasih and Anwar Mallongi and Anwar Daud and Sukri Palutturi and Stang and Razak Thaha and Erniwaty Ibrahim and Wesam Al Moudhun} } @article {1931, title = {Risk Factors for Hepatotoxicity From L-Asparaginase Chemotherapy In Children With Acute Lymphoblastic Leukemia}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {January 2023}, pages = {921-927}, type = {Original Article }, chapter = {921}, abstract = {

Introduction: L-asparaginase chemotherapy often causes hepatotoxicity and affects complete remission in pediatric acute lymphoblastic leukemia (ALL). This study aims to investigate the risk factors that affect the incidence of hepatotoxicity caused by L-asparaginase chemotherapy in ALL children. Methods: An observational study with prospective sampling was conducted at Dr. Soetomo Hospital, Surabaya. The inclusion criteria included ALL children aged 1-18 years, undergoing ALL Induction phase chemotherapy based on the 2018 Indonesian Children{\textquoteright}s ALL protocol as evidenced by bone marrow aspiration, receiving L-asparaginase chemotherapy, and obtaining written consent from parents or guardians. Each child had 3 ml of blood drawn from a peripheral vein to assess their complete blood count, alanine transaminase (ALT) levels, and albumin level. Results: Thirty-two children with ALL were collected. Two of them were excluded due to allergic reaction and enable to continue the L-asparaginase chemotherapy. Thirty of them were eligible participants. Approximately 53.3\% of ALL children aged <= seven years. Fourteen (47\%) children with ALL were included in the standard-risk group and 16 (53\%) of them included high-risk group. There were significant differences in ALT levels between the four stages of observation (p=\<0.001). Twenty-two ALL children had hepatotoxicity (73.3\%), while 8 had non-hepatotoxicity (26.7\%). Two risk factors had a significant influence on the occurrence of hepatotoxicity due to L-asparaginase chemotherapy including age and hypoalbuminemia (p=0.045, p=0.028). Conclusion: Age and hypoalbuminemia were the risk factors that might affect the incidents of hepatotoxicity. Clinical monitoring before and after treatment needs to be done to prevent poor outcomes.

}, keywords = {Acute lymphoblastic leukemia, Children, Hepatotoxicity, L-asparaginase}, doi = {10.5530/pj.2022.14.190}, author = {Agniya Ali Fahmi Hikmat and Mia Ratwita Andarsini and Bagus Setyoboedi and Maria Christina Shanty Larasati and Andi Cahyadi and I Dewa Gede Ugrasena} }